Epivir

DRUG2 trials

Sponsors

GlaxoSmithKline, Bristol-Myers Squibb

Conditions

HIV InfectionHIV InfectionsInfection, Human Immunodeficiency Virus

Phase 3

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

CompletedNCT00085943

GlaxoSmithKlineHIV Infection, Infection, Human Immunodeficiency Virus

Start: 2004-05-31Target: 866Updated: 2011-05-16

Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen

CompletedNCT00135382

Bristol-Myers SquibbHIV Infections

Start: 2002-06-30End: 2005-10-31Target: 254Updated: 2010-02-17